The Early Detection Research Group supports research that seeks to determine the effectiveness, operating characteristics and clinical impact (harms as well as benefits) of cancer early detection technologies and practices, such as imaging and molecular biomarker approaches.
Read more About the Early Detection Research Group.
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
The repository makes valuable data and biospecimens available to researchers from a large, randomized trial on the effects of screening on cancer-related mortality and secondary endpoints in people aged 55 to 74.
Cancer Data Access System (CDAS)
Submission and tracking for data from the National Lung Screening Trial (NLST) and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO).
The National Lung Screening Trial (NLST)
The National Lung Screening Trial (NLST) compared two ways of detecting lung cancer: participants who received low-dose helical CT scans had a 20% lower risk of dying from lung cancer than participants who received standard chest X-rays.